Aptevo Therapeutics (APVO) Misses Q3 EPS by 15c

Aptevo Therapeutics (NASDAQ: APVO) reported Q3 EPS of ($1.50), $0.15 worse than the analyst estimate of ($1.35).

For earnings history and earnings-related data on Aptevo Therapeutics (APVO) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Jersey Mike's Subs (JMKE) PT Raised to $30 at Tigress Financial Partners
• Piper Sandler picks Q2 Holdings as preferred stock in payments coverage